• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer.

作者信息

Fitzgerald R C

机构信息

MRC Cancer Cell Unit, Hutchison-MRC Research Centre, Hills Road, Cambridge CB2 2XZ, UK.

出版信息

Gut. 2003 Jan;52(1):16-7. doi: 10.1136/gut.52.1.16.

DOI:10.1136/gut.52.1.16
PMID:12477752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1773508/
Abstract
摘要

相似文献

1
Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer.消融性黏膜切除术是预防巴雷特食管腺癌的首选手术。
Gut. 2003 Jan;52(1):16-7. doi: 10.1136/gut.52.1.16.
2
Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods.
Gastrointest Endosc. 1999 Aug;50(2):229-40. doi: 10.1016/s0016-5107(99)70230-0.
3
Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer.消融性黏膜切除术是预防巴雷特食管腺癌的首选手术方式。
Gut. 2003 Jan;52(1):14-5. doi: 10.1136/gut.52.1.14.
4
Time to burn? Endoscopic ablation for Barrett's esophagus.是时候进行消融了？巴雷特食管的内镜下消融治疗。
Gastroenterology. 2011 Aug;141(2):417-9. doi: 10.1053/j.gastro.2011.06.025. Epub 2011 Jun 25.
5
[Barrett's neoplasia: where is the problem?].[巴雷特化生相关肿瘤：问题出在哪里？]
Zentralbl Chir. 2014 Aug;139(4):386-92. doi: 10.1055/s-0033-1360296. Epub 2014 Aug 13.
6
Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how?食管高级别异型增生和黏膜内癌的切除术：何时及如何进行？
World J Gastroenterol. 2010 Aug 14;16(30):3786-92. doi: 10.3748/wjg.v16.i30.3786.
7
Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia.巴雷特食管伴低级别异型增生的射频消融与监测内镜检查的纵向结果
Dis Esophagus. 2018 Apr 1;31(4). doi: 10.1093/dote/dox120.
8
Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus.Barrett 食管经射频消融治疗后出现黏膜下高级别异型增生和腺癌。
Gastroenterology. 2012 Sep;143(3):564-566.e1. doi: 10.1053/j.gastro.2012.04.051. Epub 2012 May 3.
9
Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma.巴雷特食管伴高级别异型增生和黏膜内腺癌的治疗。
Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):493-8. doi: 10.1586/egh.09.44.
10
The diagnosis and management of Barrett's esophagus.巴雷特食管的诊断与管理
Adv Surg. 1999;33:29-68.

引用本文的文献

1
Tumor immune microenvironment in therapy-naive esophageal adenocarcinoma could predict the nodal status.未经治疗的食管腺癌的肿瘤免疫微环境可以预测淋巴结状态。
Cancer Med. 2023 Mar;12(5):5526-5535. doi: 10.1002/cam4.5386. Epub 2022 Oct 25.
2
INK4a-ARF alterations in Barrett's epithelium, intraepithelial neoplasia and Barrett's adenocarcinoma.巴雷特食管上皮、上皮内瘤变及巴雷特腺癌中的INK4a-ARF改变
Virchows Arch. 2004 Aug;445(2):135-41. doi: 10.1007/s00428-004-1042-0. Epub 2004 Jun 8.
3
Barrett's oesophagus and adenocarcinoma.巴雷特食管与腺癌。
World J Surg Oncol. 2004 May 7;2:12. doi: 10.1186/1477-7819-2-12.

本文引用的文献

1
Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus.罗非昔布抑制环氧化酶2的表达和活性，并减少巴雷特食管中的细胞增殖。
Gastroenterology. 2002 Jul;123(1):60-7. doi: 10.1053/gast.2002.34244.
2
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus.在巴雷特食管动物模型中，COX - 2抑制剂对食管腺癌的化学预防作用。
Gastroenterology. 2002 Apr;122(4):1101-12. doi: 10.1053/gast.2002.32371.
3
The adoption of ablation therapy for Barrett's esophagus: a cohort study of gastroenterologists.巴雷特食管消融治疗的应用：胃肠病学家的队列研究
Am J Gastroenterol. 2002 Feb;97(2):279-86. doi: 10.1111/j.1572-0241.2002.05455.x.
4
Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation.内镜氩离子束血浆消融术预防巴雷特食管的肿瘤进展
Br J Surg. 2001 Oct;88(10):1357-62. doi: 10.1046/j.0007-1323.2001.01926.x.
5
Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study.热凝术联合高剂量抑酸治疗非异型增生性巴雷特食管的有效且安全的内镜逆转：一项多中心研究
Gastrointest Endosc. 2001 May;53(6):554-8. doi: 10.1067/mge.2001.114418.
6
Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression.综述文章：巴雷特食管、发育异常与药物性抑酸
Aliment Pharmacol Ther. 2001 Mar;15(3):269-76. doi: 10.1046/j.1365-2036.2001.00939.x.
7
Is there publication bias in the reporting of cancer risk in Barrett's esophagus?巴雷特食管癌症风险报告中是否存在发表偏倚？
Gastroenterology. 2000 Aug;119(2):333-8. doi: 10.1053/gast.2000.9302.
8
Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus.巴雷特食管鳞状上皮再生情况下发生的黏膜内腺癌。
Gut. 2000 Apr;46(4):574-7. doi: 10.1136/gut.46.4.574.
9
Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus.内镜下巴雷特食管逆转术后新鳞状上皮的耐久性
Gastrointest Endosc. 1999 Aug;50(2):159-64. doi: 10.1016/s0016-5107(99)70218-x.
10
Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression.
Gastrointest Endosc. 1999 May;49(5):547-53. doi: 10.1016/s0016-5107(99)70380-9.